Throughout our previous articles on the topic, we often discuss how the Children’s Hospital of Philadelphia (CHOP) has had a seemingly endless delay in their study on the effects of PEG 3350 (the main ingredient in MiraLAX) in children. A study that was originally supposed to be completed in 2015 and then by the end of 2018, is still incomplete. … [Read more...]
MiraLax Pediatric Study on Psychiatric Side Effects Projected to be Completed in 2018
Issue While MiraLax (polyethylene glycol 3350) is typically intended for use in patients 17 years of age and older, it has apparently been prescribed "off-label" for many years to children for constipation relief. What's worse is that MiraLax is typically prescribed for a maximum of seven days to adults, but some children were taking it for much … [Read more...]